The Applicant had been conducting business as a wholesale dealer in medicines and pharmaceutical products since 2002 under a permit issued by the Respondent, which was valid for one year and required annual renewal. The Applicant's last permit No. 02193 expired on 31 March 2009 without the Applicant submitting a renewal application. On 30 April 2009, the Respondent notified the Applicant of the expiry. The Applicant apologized and requested to submit a renewal application out of time. The Respondent's Legal Committee granted an extension until 31 May 2009 for payment of the renewal fee of US$1,750.00. Despite this extension, the Applicant failed to submit the renewal application by the extended deadline. Instead, the Applicant forged a wholesale dealer's permit and continued trading. In October 2009, an inspection discovered the forgery and illegal supply of medicines. Only then did the Applicant deposit the renewal fee and submit Form D.C. 7 (renewal application) dated 26 October 2009, claiming they had failed to meet the 31 May deadline because notification of the extension was only sent by email on 29 May 2009. The Respondent refused to entertain the application and offered to refund the money paid.
The application was dismissed with costs.
The binding legal principles established are: (1) A permit issued under the Medicines and Allied Substances Control Act and regulations can only be renewed before its expiry date, not after; (2) An administrative authority cannot lawfully extend statutory deadlines beyond the powers granted by the enabling legislation, and any purported extension is a legal nullity from which no rights flow; (3) An application for renewal of a pharmaceutical wholesale dealer's permit must be made in the prescribed form (Form D.C. 7) accompanied by the prescribed fee before the permit expires; informal representations or letters do not constitute a valid application; (4) A legitimate expectation under administrative law must be based on either an express promise that has been complied with or a regular practice that the claimant can reasonably expect to continue; an expectation based on non-compliance with conditions or unlawful extensions is not legitimate; (5) The remedy under section 4 of the Administrative Justice Act is only available where an administrative authority has failed to comply with section 3 in circumstances where it had a duty to act; where no valid application has been made and no lawful expectation exists, there is no duty on the authority to act.
The court made non-binding observations regarding the Applicant's conduct in forging a wholesale dealer's permit and trading using the forged permit after its legitimate permit had expired. While this conduct was noted as part of the factual background and context, the court did not make specific findings on criminal liability or impose sanctions related to the forgery, as this was not the subject of the application before it. The court's comment that the Applicant's submission that representations should be taken as an application was 'simply disingenuous and cannot be taken seriously' reflects judicial disapproval of the Applicant's approach but was not essential to the legal determination. The court also implicitly commented on the importance of fairness as the overriding factor in administrative law when citing Health Professions Council v McGown, though this broader principle was not fully developed in the judgment as it was clear the Applicant had not met the threshold requirements for administrative law protection.
This case is significant in Zimbabwean administrative law as it clarifies the limits of the doctrine of legitimate expectation and the strict requirements for renewal of regulatory permits in the pharmaceutical industry. It establishes that administrative authorities cannot extend statutory deadlines beyond their legislative powers, and that such purported extensions are legal nullities. The case reinforces the principle that compliance with statutory procedural requirements is mandatory and that legitimate expectations must be grounded in either express promises that are complied with or established regular practice. It also confirms that courts will not grant administrative law remedies where applicants have failed to follow prescribed statutory procedures, particularly in highly regulated sectors such as pharmaceuticals where public health and safety are at stake.